Terrence W. Norchi

CEO of Arch Therapeutics, Inc.

Terrence W. Norchi, MD is president and CEO of Framingham, MA-based Arch Therapeutics, Inc. Arch's flagship development stage product candidate, the AC5 Surgical Hemostatic Device™, is being designed to achieve hemostasis in minimally invasive and open surgical procedures.

Want to write for Entrepreneur too? Apply to join Entrepreneur Leadership network.